Study to Evaluate the Pharmacokinetics and Pharmacodynamics of JMI-001

NCT03183297 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Veisalgia

Interventions

DRUG: JMI-001
DRUG: Naproxen
DRUG: Fexofenadine
DRUG: placebo

Sponsor

Sen-Jam Pharmaceutical